Lung expression of interleukin-13 (IL-13) and interferon gamma (IFNg) in emphysema in human
A. Boutten, M. Bonay, S. Laribe, G. Leseche, Y. Castier, V. Leçon-Malas, M. Fournier, G. Durand, M. Aubier, M. Dehoux, B. Crestani (Paris, Clichy, France)
Source: Annual Congress 2002 - Biological disease markers in airways and parenchymal lung disease
Disease area: Airway diseases
Rating:
You must login to grade this presentation.
Share or cite this content
Citations should be made in the following way:
A. Boutten, M. Bonay, S. Laribe, G. Leseche, Y. Castier, V. Leçon-Malas, M. Fournier, G. Durand, M. Aubier, M. Dehoux, B. Crestani (Paris, Clichy, France). Lung expression of interleukin-13 (IL-13) and interferon gamma (IFNg) in emphysema in human. Eur Respir J 2002; 20: Suppl. 38, 3608
You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
Related content which might interest you:
Related content which might interest you:
Lung CD4+ T-cells in patients with lung fibrosis produce pro-fibrotic interleukin-13 together with interferon-? Source: Eur Respir J, 57 (3) 2000983; 10.1183/13993003.00983-2020 Year: 2021
Cytokine modulators as novel therapies for airway disease Source: Eur Respir J 2001; 18: 67S-77S Year: 2001
Decreased levels of CXC angiogenic chemokines (IL-8, ENA-78 and GRO-α) in BALF after interferon gamma-1b treatment in IPF patients Source: Eur Respir J 2005; 26: Suppl. 49, 267s Year: 2005
Impared endotoxin-induced Interleukin (IL) -5 and Interferon- (IFN) γ expression in peripheral blood T-lymphocytes from atopic asthmatics Source: Eur Respir J 2003; 22: Suppl. 45, 291s Year: 2003
Combined effect of anti-IgE (omalizumab) and specific immunotherapy (SIT) on in vitro release of leukotrienes (LT) and the cytokines IL-4 and interferon-gamma (IFN) Source: Eur Respir J 2002; 20: Suppl. 38, 588s Year: 2002
The ratio of interleukine-4( IL-4) and interferon-γ( IFN- γ) in expired air condensate(EAC) of atopic children Source: Eur Respir J 2004; 24: Suppl. 48, 271s Year: 2004
Chemokinome characterization in human lung macrophages following stimulation with Th2-type cytokines IL-4 or IL-13 Source: Annual Congress 2012 - Update on neutrophil and macrophage function in COPD Year: 2012
Interleukin-18, interleukin-12, interferon γ and interleukin-18 receptor expression is decreased in the recovery phase of pulmonary sarcoidosis Source: Eur Respir J 2001; 18: Suppl. 33, 366s Year: 2001
Association of C-703T (IL-5 gene) and A-80G (IL-5RA gene) polymorphisms with bronchial asthma Source: Eur Respir J 2001; 18: Suppl. 33, 370s Year: 2001
The expression of IL17RA (the common subunit of IL-17A and IL-25 receptor) on sputum macrophages in asthma patients Source: Virtual Congress 2021 – Pearls in immunology, outcome studies and clinical trials in asthma, alpha-1 antitrypsin deficiency and COPD Year: 2021
IL-9 and IL-9 receptor (IL-9r) expression in BALF lymphocytes in ILD patients: preliminary results. Source: International Congress 2017 – The wide spectrum of ILDs Year: 2017
Polymorphisms of the IL-4 and IL-4 receptor alpha chain genes and bronchial asthma Source: Eur Respir J 2005; 26: Suppl. 49, 708s Year: 2005
Difference of production interleukin-4 and interferon gamma in serum in children with cystic fibrosis Source: Eur Respir J 2002; 20: Suppl. 38, 529s Year: 2002
IL-18 and IL-12 induce inflammatory cytokines, chemokine ligand 9 (CXCL9) and T cell infiltration in pulmonary tissue Source: Annual Congress 2011 - Lung cell injury and repair Year: 2011
Interleukin (IL-13) modulates allergen-induced airway hyperresponsiveness by a pathway independent of IL-5 or eotaxin in mice Source: Eur Respir J 2003; 22: Suppl. 45, 194s Year: 2003
Interferon gamma decreases interleukin-8 production and neurokinin-1 receptor expression in lung alveolar epithelial cells Source: Eur Respir J 2001; 18: Suppl. 33, 80s Year: 2001
Levels of interleukins IL-4, IL-6, IL-8 and TNFa in sera of patients with tuberculosis before and during treatment Source: Eur Respir J 2002; 20: Suppl. 38, 556s Year: 2002
Interleukin -18 (IL-18) and tumor necrosis factor (TNF) in sarcoidosis Source: Eur Respir J 2002; 20: Suppl. 38, 434s Year: 2002
The levels of osteoprotegerin (OPG), interleukin 18 (IL-18) and soluble interleukin 2 receptor (sIL-2R) in serum during chemotherapy of lung cancer Source: Eur Respir J 2004; 24: Suppl. 48, 318s Year: 2004
Interferon (-alpha, -beta, and -omega) receptor 2 (IFNAR2) is a prognostic biomarker for lung cancer Source: Annual Congress 2011 - Innovative diagnostic methods for lung cancer Year: 2011